Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.25M | 225.07M | 150.49M | 100.78M | 86.69M |
| Total Other Revenue | 978.00K | 536.00K | 377.00K | 226.00K | -- |
| Total Revenue | 37.23M | 225.61M | 150.86M | 101.01M | 86.69M |
| Cost of Revenue | 25.77M | 44.74M | 36.25M | 27.63M | 23.72M |
| Gross Profit | 11.46M | 180.87M | 114.61M | 73.38M | 62.97M |
| SG&A Expenses | 61.33M | 100.17M | 79.23M | 73.81M | 72.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 102.26M | 155.20M | 128.70M | 111.84M | 106.87M |
| Operating Income | -65.03M | 70.41M | 22.17M | -10.83M | -20.18M |
| Income Before Tax | -68.47M | 63.43M | 21.16M | -11.83M | -25.78M |
| Income Tax Expenses | -15.32M | 19.73M | -407.00K | -2.44M | -6.94M |
| Earnings from Continuing Operations | -53.16M | 43.70M | 21.57M | -9.39M | -18.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.16M | 43.70M | 21.57M | -9.39M | -18.84M |
| EBIT | -65.03M | 70.41M | 22.17M | -10.83M | -20.18M |
| EBITDA | -55.15M | 75.27M | 27.04M | -6.26M | -15.89M |
| EPS Basic | -0.44 | 0.28 | 0.11 | -0.06 | -0.17 |
| Normalized Basic EPS | -0.32 | 0.35 | 0.11 | -0.05 | -0.10 |
| EPS Diluted | -0.44 | 0.26 | 0.11 | -0.06 | -0.17 |
| Normalized Diluted EPS | -0.32 | 0.33 | 0.11 | -0.05 | -0.10 |
| Average Basic Shares Outstanding | 127.80M | 126.91M | 126.88M | 126.86M | 126.30M |
| Average Diluted Shares Outstanding | 127.80M | 132.21M | 130.85M | 126.86M | 126.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |